News section

home  |  news  |  solutions  |  forum  |  careers  |  calendar  |  yellow pages  |  advertise  |  contacts

 

According to EuropaBio, EU Environment Ministers vote against sound science

Brussels, Belgium
December 18 2006
EU's Environment Council reject two proposals from the Commission (13764/06 and 13767/06), requesting Austria to repeal the prohibition of use and sale on its territory of two genetically modified maize

The EU's Environment Council has today delivered a blow to the prospects for growth and jobs in Europe, according to EuropaBio. By backing Austria's illegal ban on the cultivation of EU-approved GM crops, the Council has seriously damaged the credibility of the regulatory system on which much of Europe's innovative and industrial capacity relies, says the European biotechnology industry association. Today’s vote denies Austrian farmers the freedom of choice and the possibility to grow GM if they want to.

"At issue is whether scientific opinions are to be respected and whether decision-making is to be rational in Europe", said Johan Vanhemelrijck, EuropaBio's Secretary General.

The European Commission had asked the Council to overturn the Austrian ban on two genetically-modified maize seeds which have repeatedly been pronounced safe after protracted EU reviews. One of the products, Mon810, is designed to resist the European corn borer, a widespread moth larva that can destroy crops. It is already grown in Spain, France, Germany, Portugal and the Czech Republic without any safety or environmental issues, thus demonstrating that Austria's objections are without foundation. The other, T25, permits farmers to use a broad-spectrum herbicide for weed control without damaging the crop. (Details of the products and their safety assessment appear below.)

But a qualified majority of member states today rejected the European Commission call for the prohibition to be repealed.

"The EU's own scientific assessments have repeatedly made clear that there is no reason to consider that the products constitute a risk to human health or the environment", said Johan Vanhemelrijck. "The Council is undermining the authority of its own expert advisors. Europe is the only region in the world that votes on its science, the community must start to believe its own scientific opinions.”

This is the second time the Council has refused Commission proposals to overturn these illegal bans. Already in June 2005 a qualified majority of member states upheld Austria's position, and required further information.

"Today's decision by the Council displays an alarming indifference to the EU's own rules, and to common sense", said Simon Barber, Director of EuropaBio. "The further information the Council requested in 2005 has now been provided, and it indicates unambiguously that the products carry none of the risks alleged. But still the Council declines to follow the advice of the EU's own expert advisory bodies. This departure from rational decision-making is disconcerting - not only for these two products, but for every innovator in every industrial sector that is subject to EU regulation. If the EU ceases to follow its own rules, innovators and investors are left in a state of profound uncertainty - and that is deeply discouraging for growth and for jobs. It will be no surprise if this continued disarray in the EU induces more companies to move their research and investment abroad to regions with more predictable and consistent regulatory regimes".

EuropaBio points out that the knowledge-based bio-economy, repeatedly recognised by the EU to be a crucial element in the renewed jobs and growth strategy, can fully deliver on its potential only if the regulatory framework is consistent and consistently implemented. The European Commission has recognised this, and so too have many member states. But other member states continue to put these opportunities at risk by allowing local political considerations to distort the decision-making process.

Given a predictable regulatory environment, the sector can:

  • exploit its innovative capacity to diversify from food/feed into renewable bio-based resources and bio-energy;

  • increasingly provide raw-biomaterials for other industrial sectors

  • maintain its investment in European research and innovation

MON 810

In 1998 the European Commission gave its consent for the marketing of Monsanto's Zea Mays L. line MON 810, and France authorised the product. Austria prohibited the use and sale of the product in 1999, but its justifications for the prohibition were rejected by the EU's Scientific Committee on Plants in 1999, and in 2004 and again in 2006 by the European Food Safety Authority.

T25

In 1998 the European Commission gave its consent for the marketing of Aventis' Zea Mays L. line T 25, and France authorised the product. Austria prohibited the use and sale of the product in May 2000, but its justifications for the prohibition were rejected in 2001 by the Scientific Committee on Plants, and by EFSA in 2004, and again in 2006

In both cases, EFSA concluded that there is no reason to believe that the continued placing on the market of these products "is likely to cause any adverse effects for human and animal health or the environment under the conditions of its consent."

EuropaBio, the European Association for Bioindustries, has 70 direct members operating Worldwide, 12 associate members and 5 bioregions as well as 24 national biotechnology associations representing some 1800 small and medium sized enterprises involved in research and development, testing, manufacturing and distribution of biotechnology products.

News release

Other news from this source

17,876

Back to main news page

The news release or news item on this page is copyright © 2006 by the organization where it originated.
The content of the SeedQuest website is copyright © 1992-2006 by SeedQuest - All rights reserved
Fair Use Notice